Annual Net Income
-$60.61 M
-$35.66 M-142.93%
December 31, 2023
Summary
- As of February 7, 2025, BLRX annual net profit is -$60.61 million, with the most recent change of -$35.66 million (-142.93%) on December 31, 2023.
- During the last 3 years, BLRX annual net income has fallen by -$30.59 million (-101.91%).
- BLRX annual net income is now -2990.51% below its all-time high of $2.10 million, reached on December 31, 2010.
Performance
BLRX Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$5.82 M
-$6.31 M-1302.89%
September 1, 2024
Summary
- As of February 7, 2025, BLRX quarterly net profit is -$5.82 million, with the most recent change of -$6.31 million (-1302.89%) on September 1, 2024.
- Over the past year, BLRX quarterly net income has increased by +$10.20 million (+63.66%).
- BLRX quarterly net income is now -129.13% below its all-time high of $19.99 million, reached on September 30, 2010.
Performance
BLRX Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$19.92 M
+$10.20 M+33.87%
September 1, 2024
Summary
- As of February 7, 2025, BLRX TTM net profit is -$19.92 million, with the most recent change of +$10.20 million (+33.87%) on September 1, 2024.
- Over the past year, BLRX TTM net income has increased by +$32.54 million (+62.03%).
- BLRX TTM net income is now -332.59% below its all-time high of $8.56 million, reached on September 30, 2010.
Performance
BLRX TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
BLRX Net Income Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -142.9% | +63.7% | +62.0% |
3 y3 years | -101.9% | -1.9% | +42.7% |
5 y5 years | -164.0% | -1.9% | +42.7% |
BLRX Net Income Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -142.9% | at low | -1302.9% | +68.6% | at high | +67.1% |
5 y | 5-year | -142.9% | at low | -1302.9% | +68.6% | at high | +67.1% |
alltime | all time | -2990.5% | at low | -129.1% | +68.6% | -332.6% | +67.1% |
BioLineRx Net Income History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$5.82 M(-1302.9%) | -$19.92 M(-33.9%) |
Jun 2024 | - | $484.00 K(-169.5%) | -$30.12 M(-38.7%) |
Mar 2024 | - | -$696.00 K(-95.0%) | -$49.15 M(-18.9%) |
Dec 2023 | -$60.61 M(+142.9%) | -$13.88 M(-13.3%) | -$60.61 M(+15.5%) |
Sep 2023 | - | -$16.02 M(-13.6%) | -$52.46 M(+21.2%) |
Jun 2023 | - | -$18.55 M(+52.5%) | -$43.28 M(+34.5%) |
Mar 2023 | - | -$12.16 M(+112.2%) | -$32.18 M(+29.0%) |
Dec 2022 | -$24.95 M(-7.8%) | -$5.73 M(-16.3%) | -$24.95 M(+6.1%) |
Sep 2022 | - | -$6.85 M(-8.0%) | -$23.52 M(+5.1%) |
Jun 2022 | - | -$7.44 M(+51.0%) | -$22.39 M(+2.8%) |
Mar 2022 | - | -$4.93 M(+14.5%) | -$21.79 M(-19.4%) |
Dec 2021 | -$27.05 M(-9.9%) | -$4.30 M(-24.7%) | -$27.05 M(-22.1%) |
Sep 2021 | - | -$5.72 M(-16.5%) | -$34.74 M(+3.3%) |
Jun 2021 | - | -$6.84 M(-32.9%) | -$33.64 M(+0.2%) |
Mar 2021 | - | -$10.19 M(-15.0%) | -$33.57 M(+11.8%) |
Dec 2020 | -$30.02 M(+18.0%) | -$11.99 M(+159.6%) | -$30.02 M(+7.6%) |
Sep 2020 | - | -$4.62 M(-31.8%) | -$27.90 M(+2.5%) |
Jun 2020 | - | -$6.77 M(+1.9%) | -$27.22 M(+5.0%) |
Mar 2020 | - | -$6.64 M(-32.7%) | -$25.94 M(+1.9%) |
Dec 2019 | -$25.45 M(+10.8%) | -$9.87 M(+150.6%) | -$25.45 M(+19.9%) |
Sep 2019 | - | -$3.94 M(-28.2%) | -$21.23 M(-10.1%) |
Jun 2019 | - | -$5.49 M(-10.9%) | -$23.62 M(+3.0%) |
Mar 2019 | - | -$6.16 M(+8.9%) | -$22.92 M(-0.2%) |
Dec 2018 | -$22.96 M(-5.7%) | -$5.65 M(-10.6%) | -$22.96 M(-6.9%) |
Sep 2018 | - | -$6.32 M(+32.1%) | -$24.67 M(-3.6%) |
Jun 2018 | - | -$4.79 M(-22.7%) | -$25.59 M(-0.4%) |
Mar 2018 | - | -$6.20 M(-15.8%) | -$25.70 M(+5.5%) |
Dec 2017 | -$24.35 M | -$7.36 M(+1.6%) | -$24.35 M(+14.4%) |
Sep 2017 | - | -$7.24 M(+47.9%) | -$21.28 M(+15.8%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2017 | - | -$4.90 M(+0.9%) | -$18.37 M(+6.8%) |
Mar 2017 | - | -$4.86 M(+13.3%) | -$17.21 M(+8.6%) |
Dec 2016 | -$15.84 M(+10.0%) | -$4.29 M(-1.1%) | -$15.84 M(+4.2%) |
Sep 2016 | - | -$4.33 M(+16.0%) | -$15.21 M(+21.7%) |
Jun 2016 | - | -$3.73 M(+7.1%) | -$12.50 M(-7.9%) |
Mar 2016 | - | -$3.49 M(-4.5%) | -$13.58 M(-5.7%) |
Dec 2015 | -$14.40 M(+30.0%) | -$3.65 M(+124.6%) | -$14.40 M(-3.6%) |
Sep 2015 | - | -$1.63 M(-66.2%) | -$14.94 M(+6.6%) |
Jun 2015 | - | -$4.81 M(+11.6%) | -$14.01 M(+5.6%) |
Mar 2015 | - | -$4.31 M(+2.8%) | -$13.27 M(+19.8%) |
Dec 2014 | -$11.08 M(-34.9%) | -$4.19 M(+499.0%) | -$11.07 M(+0.7%) |
Sep 2014 | - | -$700.00 K(-82.8%) | -$10.99 M(-27.9%) |
Jun 2014 | - | -$4.07 M(+92.3%) | -$15.24 M(-1.3%) |
Mar 2014 | - | -$2.12 M(-48.6%) | -$15.44 M(-8.3%) |
Dec 2013 | -$17.02 M(-16.6%) | -$4.11 M(-17.0%) | -$16.84 M(-15.7%) |
Sep 2013 | - | -$4.95 M(+16.0%) | -$19.99 M(-3.8%) |
Jun 2013 | - | -$4.27 M(+21.4%) | -$20.77 M(+7.1%) |
Mar 2013 | - | -$3.51 M(-51.6%) | -$19.40 M(-6.3%) |
Dec 2012 | -$20.42 M(+54.8%) | -$7.25 M(+26.5%) | -$20.71 M(+21.6%) |
Sep 2012 | - | -$5.74 M(+98.4%) | -$17.03 M(+27.0%) |
Jun 2012 | - | -$2.89 M(-40.1%) | -$13.41 M(-12.4%) |
Mar 2012 | - | -$4.83 M(+35.0%) | -$15.31 M(+10.9%) |
Dec 2011 | -$13.19 M(-728.8%) | -$3.58 M(+68.7%) | -$13.81 M(-14.8%) |
Sep 2011 | - | -$2.12 M(-55.8%) | -$16.21 M(-374.7%) |
Jun 2011 | - | -$4.79 M(+44.1%) | $5.90 M(+71.6%) |
Mar 2011 | - | -$3.32 M(-44.3%) | $3.44 M(+32.6%) |
Dec 2010 | $2.10 M | -$5.97 M(-129.9%) | $2.59 M(-69.7%) |
Sep 2010 | - | $19.99 M(-375.6%) | $8.56 M(-175.0%) |
Jun 2010 | - | -$7.25 M(+73.9%) | -$11.42 M(+173.9%) |
Mar 2010 | - | -$4.17 M | -$4.17 M |
FAQ
- What is BioLineRx annual net profit?
- What is the all time high annual net income for BioLineRx?
- What is BioLineRx annual net income year-on-year change?
- What is BioLineRx quarterly net profit?
- What is the all time high quarterly net income for BioLineRx?
- What is BioLineRx quarterly net income year-on-year change?
- What is BioLineRx TTM net profit?
- What is the all time high TTM net income for BioLineRx?
- What is BioLineRx TTM net income year-on-year change?
What is BioLineRx annual net profit?
The current annual net income of BLRX is -$60.61 M
What is the all time high annual net income for BioLineRx?
BioLineRx all-time high annual net profit is $2.10 M
What is BioLineRx annual net income year-on-year change?
Over the past year, BLRX annual net profit has changed by -$35.66 M (-142.93%)
What is BioLineRx quarterly net profit?
The current quarterly net income of BLRX is -$5.82 M
What is the all time high quarterly net income for BioLineRx?
BioLineRx all-time high quarterly net profit is $19.99 M
What is BioLineRx quarterly net income year-on-year change?
Over the past year, BLRX quarterly net profit has changed by +$10.20 M (+63.66%)
What is BioLineRx TTM net profit?
The current TTM net income of BLRX is -$19.92 M
What is the all time high TTM net income for BioLineRx?
BioLineRx all-time high TTM net profit is $8.56 M
What is BioLineRx TTM net income year-on-year change?
Over the past year, BLRX TTM net profit has changed by +$32.54 M (+62.03%)